169 related articles for article (PubMed ID: 31053096)
1. The association between post-treatment surveillance testing and survival in stage II and III colon cancer patients: An observational comparative effectiveness study.
Hines RB; Jiban MJH; Specogna AV; Vishnubhotla P; Lee E; Zhang S
BMC Cancer; 2019 May; 19(1):418. PubMed ID: 31053096
[TBL] [Abstract][Full Text] [Related]
2. Surveillance Colonoscopy in Older Stage I Colon Cancer Patients and the Association With Colon Cancer-Specific Mortality.
Hines RB; Jiban MJH; Specogna AV; Vishnubhotla P; Lee E; Troy SP; Zhang S
Am J Gastroenterol; 2020 Jun; 115(6):924-933. PubMed ID: 32142485
[TBL] [Abstract][Full Text] [Related]
3. Characteristics Associated With Nonreceipt of Surveillance Testing and the Relationship With Survival in Stage II and III Colon Cancer.
Hines RB; Jiban MJH; Lee E; Odahowski CL; Wallace AS; Adams SJE; Rahman SMM; Zhang S
Am J Epidemiol; 2021 Feb; 190(2):239-250. PubMed ID: 32902633
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
5. Health and Economic Impact of Intensive Surveillance for Distant Recurrence After Curative Treatment of Colon Cancer: A Mathematical Modeling Study.
Wanis KN; Maleyeff L; Van Koughnett JAM; H D Colquhoun P; Ott M; Leslie K; Hernandez-Alejandro R; Kim JJ
Dis Colon Rectum; 2019 Jul; 62(7):872-881. PubMed ID: 31188189
[TBL] [Abstract][Full Text] [Related]
6. Post-treatment surveillance testing of patients with colorectal cancer and the association with survival: protocol for a retrospective cohort study of the Surveillance, Epidemiology, and End Results (SEER)-Medicare database.
Hines RB; Jiban MJH; Choudhury K; Loerzel V; Specogna AV; Troy SP; Zhang S
BMJ Open; 2018 Apr; 8(4):e022393. PubMed ID: 29705770
[TBL] [Abstract][Full Text] [Related]
7. Estimates of Overall Survival in Patients With Cancer Receiving Different Treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)-Medicare Linked Database.
Petito LC; García-Albéniz X; Logan RW; Howlader N; Mariotto AB; Dahabreh IJ; Hernán MA
JAMA Netw Open; 2020 Mar; 3(3):e200452. PubMed ID: 32134464
[TBL] [Abstract][Full Text] [Related]
8. Current treatment and surveillance modalities are not sufficient for advanced stage III colon cancer: Result from a multicenter cohort analysis.
Li J; Xie Y; Huang Z; Shen D; Zhuang Z; Zhu M; Huang Y; He R; Wang X; Huang M; Luo Y; Yu H
Cancer Med; 2021 Dec; 10(24):8924-8933. PubMed ID: 34786881
[TBL] [Abstract][Full Text] [Related]
9. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.
Thirunavukarasu P; Talati C; Munjal S; Attwood K; Edge SB; Francescutti V
JAMA Surg; 2015 Aug; 150(8):747-755. PubMed ID: 26083632
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population-Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-2009.
Du XL; Zhang Y; Parikh RC; Lairson DR; Cai Y
J Am Geriatr Soc; 2015 Aug; 63(8):1570-82. PubMed ID: 26200214
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data.
Weiss JM; Schumacher J; Allen GO; Neuman H; Lange EO; Loconte NK; Greenberg CC; Smith MA
Ann Surg Oncol; 2014 Jun; 21(6):1781-91. PubMed ID: 24643898
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.
Hsiao FY; Mullins CD; Onukwugha E; Pandya N; Hanna N
J Am Geriatr Soc; 2011 Sep; 59(9):1717-23. PubMed ID: 21831168
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data.
Weiss JM; Pfau PR; O'Connor ES; King J; LoConte N; Kennedy G; Smith MA
J Clin Oncol; 2011 Nov; 29(33):4401-9. PubMed ID: 21969498
[TBL] [Abstract][Full Text] [Related]
15. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
[TBL] [Abstract][Full Text] [Related]
16. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
[TBL] [Abstract][Full Text] [Related]
17. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
[TBL] [Abstract][Full Text] [Related]
18. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
[TBL] [Abstract][Full Text] [Related]
19. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.
O'Connor ES; Greenblatt DY; LoConte NK; Gangnon RE; Liou JI; Heise CP; Smith MA
J Clin Oncol; 2011 Sep; 29(25):3381-8. PubMed ID: 21788561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
